These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 7565783)
1. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Rooney JW; Sun YL; Glimcher LH; Hoey T Mol Cell Biol; 1995 Nov; 15(11):6299-310. PubMed ID: 7565783 [TBL] [Abstract][Full Text] [Related]
2. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. Kaminuma O; Deckert M; Elly C; Liu YC; Altman A Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617 [TBL] [Abstract][Full Text] [Related]
3. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Shapiro VS; Truitt KE; Imboden JB; Weiss A Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340 [TBL] [Abstract][Full Text] [Related]
4. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. Lindgren H; Axcrona K; Leanderson T J Immunol; 2001 Apr; 166(7):4578-85. PubMed ID: 11254715 [TBL] [Abstract][Full Text] [Related]
5. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. Bodor J; Habener JF J Biol Chem; 1998 Apr; 273(16):9544-51. PubMed ID: 9545284 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236 [TBL] [Abstract][Full Text] [Related]
7. Characterization of P5, a novel NFAT/AP-1 site in the human IL-4 promoter. Burke TF; Casolaro V; Georas SN Biochem Biophys Res Commun; 2000 Apr; 270(3):1016-23. PubMed ID: 10772943 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP. Shapiro VS; Mollenauer MN; Weiss A J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666 [TBL] [Abstract][Full Text] [Related]
9. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538 [TBL] [Abstract][Full Text] [Related]
11. The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells. Sweetser MT; Hoey T; Sun YL; Weaver WM; Price GA; Wilson CB J Biol Chem; 1998 Dec; 273(52):34775-83. PubMed ID: 9857002 [TBL] [Abstract][Full Text] [Related]
12. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Decker EL; Nehmann N; Kampen E; Eibel H; Zipfel PF; Skerka C Nucleic Acids Res; 2003 Feb; 31(3):911-21. PubMed ID: 12560487 [TBL] [Abstract][Full Text] [Related]
13. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. Tsytsykova AV; Tsitsikov EN; Geha RS J Biol Chem; 1996 Feb; 271(7):3763-70. PubMed ID: 8631992 [TBL] [Abstract][Full Text] [Related]
14. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site. Campbell PM; Pimm J; Ramassar V; Halloran PF Transplantation; 1996 Mar; 61(6):933-9. PubMed ID: 8623163 [TBL] [Abstract][Full Text] [Related]
15. Recognition of NFATp/AP-1 composite elements within genes induced upon the activation of immune cells. Kel A; Kel-Margoulis O; Babenko V; Wingender E J Mol Biol; 1999 May; 288(3):353-76. PubMed ID: 10329147 [TBL] [Abstract][Full Text] [Related]
16. Grb3-3 is up-regulated in HIV-1-infected T-cells and can potentiate cell activation through NFATc. Li X; Multon MC; Henin Y; Schweighoffer F; Venot C; Josef J; Zhou C; LaVecchio J; Stuckert P; Raab M; Mhashilkar A; Tocque B; Marasco WA J Biol Chem; 2000 Oct; 275(40):30925-33. PubMed ID: 10906142 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter. Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260 [TBL] [Abstract][Full Text] [Related]
18. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Cockerill PN; Bert AG; Jenkins F; Ryan GR; Shannon MF; Vadas MA Mol Cell Biol; 1995 Apr; 15(4):2071-9. PubMed ID: 7891702 [TBL] [Abstract][Full Text] [Related]
19. Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding. Parra E; Varga M; Hedlund G; Kalland T; Dohlsten M Mol Cell Biol; 1997 Mar; 17(3):1314-23. PubMed ID: 9032258 [TBL] [Abstract][Full Text] [Related]
20. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]